The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question\[s\] it aims to answer are: * \[question 1\] prevalence of NAFLD in CKD patients. * \[question 2\] the relationship between NAFLD and CKD.
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question\[s\] it aims to answer are: * \[question 1\] prevalence of NAFLD in CKD patients. * \[question 2\] the relationship between NAFLD and CKD.
Study Type
OBSERVATIONAL
Enrollment
200
abdominal ultrasound
assessment of Liver regarding fatty liver disease by Ultrasound.
Time frame: 1 year
liver enzymes
participants will undergo assessment of liver enzymes (AST and ALT) and results will be reporeted in a table.
Time frame: 1 year
Fibroscan
participants will undergo fibroscanning of the liver to assess NAFLD and results will be reported in a table.
Time frame: 1 year
BUN, Cr level and estimated GFR
participants will be assessed regarding BUN, CR and estimated GFR to confirm and follow up CKD patients involved in the study.
Time frame: 1 year
Lipid Profile
participants will be assessed regarding Cholesterol level, Triglycerides, HDL and LDL. results will be reported in a table
Time frame: 1 year
Complete Blood Picture (WBCs, HB, Patelets
total leucocytic count Hemoglobin level and platelet count will be assessed in our patients and will be reported in a table
Time frame: 1 year
serum Uric Acid
serum uric acid will be assessed and reported in our patients
Time frame: 1 year
Waist Circumference
waist circumference measurement.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Body Mass Index
BMI will also be calculated.
Time frame: 1 year